Latest AI and machine learning research in chemotherapy for healthcare professionals.
BACKGROUND: Neoadjuvant therapy (NAT) is crucial for locally advanced breast cancer, but post-NAT lymph node assessment is challenging due to histological changes. Current methods like immunohistochemistry (IHC) are labor-intensive and imprecise in distinguishing isolated tumor cells (ITCs), micro-metastases (Micro), and macro-metastases (Macro). We aimed to develop and validate an AI-driven model...
Neoadjuvant therapy (NAT) has strengthened systemic control in breast cancer and promoted precision de-escalation of axillary management. For clinically node-negative patients, evidence supports sentinel lymph node biopsy (SLNB) after NAT; among human epidermal growth factor receptor 2(HER2)-positive and triple-negative breast cancer patients achieving breast pathological complete response, the ri...
For locally advanced rectal cancer (LARC), neoadjuvant chemoradiotherapy (nCRT) combined with total mesorectal excision has emerged as the standard th...
BACKGROUND: Cardiovascular disease (CVD) is a major concern among cancer survivors. However, the intersection of cancer and CVD has only recently gain...
Ambient fine particulate matter (PM2.5) is a chemically complex mixture whose health impacts are not fully captured by particle mass. Here, we develop...
Engineering the surface structure of catalysts is critical for achieving high intrinsic activity in the oxygen reduction reaction (ORR). We report a m...
BACKGROUND: Cervical cancer (CC) ranks among the most prevalent malignant neoplasms affecting women worldwide. Tumor recurrence, distant metastases, a...
INTRODUCTION: Pathological complete response (pCR) is a key prognostic indicator in breast cancer (BC) patients receiving neoadjuvant chemotherapy (NA...
Ki-67 is a well-established marker of tumour proliferation and an important prognostic and predictive biomarker in breast cancer, particularly in horm...
Despite remarkable achievements in infectious disease control, more than 20 major pathogens responsible for significant global morbidity and mortality...
PURPOSE: Response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer remains heterogeneous. This exploratory study evaluated whether radiomics f...
Triple-negative breast cancer (TNBC), being one of the most aggressive subtypes of breast malignancies, is characterized by poor prognosis and limited...
BACKGROUND: Ovarian cancer (OVCA) is a common and highly aggressive gynecologic malignancy often diagnosed at advanced stages. Approximately 30% of pa...
RATIONALE AND OBJECTIVES: Although accurate preoperative prediction of sentinel lymph node (SLN) status in operable early-stage breast cancer (EBC) af...
Neoadjuvant chemoradiotherapy (nCRT) is standard for locally advanced rectal cancer but increases postoperative complication (POC) risks due to tissue...
PURPOSE OF REVIEW: Advanced gynecologic cancers are treated broadly, with variable outcomes, even when selected by traditional precision oncology biom...
Perfluorooctanoic acid (PFOA), a persistent environmental pollutant, represents a chronic environmental stressor, yet its role in osteosarcoma progres...
BACKGROUND: Clavien-Dindo (CD) grade ≥II complications occur in roughly one in five patients after curative gastrectomy for gastric cancer and indepen...
Advanced pancreatic ductal adenocarcinoma (PDAC) often progresses rapidly during chemotherapy despite initial assessments of stable disease or partial...
Aging affects lung function, predisposing older adults to respiratory diseases; however, the cellular and molecular mechanisms of lung aging are not f...